J. D. Vos

发表

Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays

J. D. Vos, T. Thykjær, K. Tarte, 2002, Oncogene.

CD 200 : a putative therapeutic target in cancer

J. D. Vos, T. Rème, B. Klein, 2017 .

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells

J. D. Vos, T. Rème, M. Jourdan, 2005, Oncogene.

Survival and Proliferation Factors of Normal and Malignant Plasma Cells

J. D. Vos, K. Tarte, M. Jourdan, 2003, International journal of hematology.

A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells

J. D. Vos, M. Jourdan, B. Klein, 2003, Oncogene.

Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1

J. D. Vos, M. Jourdan, B. Klein, 2000, Cell Death and Differentiation.

Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

J. D. Vos, D. Bouscary, F. Picard, 1997, Leukemia.

Targeting NF‐κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth

J. D. Vos, T. Rème, M. Jourdan, 2007, British journal of haematology.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

Human B Cell to Plasma Cell Differentiation Preplasmablast Population in the Process of Characterization of a Transitional

J. D. Vos, K. Tarte, T. Rème, 2011 .

Determined by Microarray Analysis Expression Patterns and Prognosis Value Cancer/Testis Genes in Multiple Myeloma:

J. D. Vos, P. Raynaud, V. Pantesco, 2007 .

101 Apoptosis and fas antigen (CD95) expression in myclodysplasia

J. D. Vos, D. Bouscary, F. Picard, 1997 .

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

J. D. Vos, V. Pantesco, B. Klein, 2009, Oncogene.

Molecular Classification of Multiple Myeloma (MM) Based on Gene Expression Profiling (GEP) and Fluorescence In Situ Hybridisation (FISH) Is an Independent Predictor for Event Free Survival (EFS).

J. D. Vos, T. Rème, J. Rossi, 2005 .

University of Groningen The role of alloresponsive Ly49+ NK cells in rat islet allograft failure in the presence and absence of cytomegalovirus Smelt,

J. D. Vos, P. Vos, M. Faas, 2018 .

Cellules souches pluripotentes de rat : so what ?

J. D. Vos, 2009 .

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

J. Downing, S. Shurtleff, J. D. Vos, 2008 .

Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis

J. D. Vos, K. Tarte, M. Baia, 2009, Leukemia.

Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes

J. D. Vos, J. Dongen, A. Langerak, 2007, Leukemia.

Analysis of replication profiles reveals key role of RFC-Ctf18 in yeast replication stress response

Philippe Pasero, Aubin Thomas, John De Vos, 2010, Nature Structural &Molecular Biology.

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study

J. D. Vos, P. Brousset, J. Soulier, 2009, Leukemia.

Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma

J. D. Vos, G. Requirand, T. Rème, 2006, Oncogene.

Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells

J. D. Vos, M. Jourdan, J. Rossi, 2002, Oncogene.

Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription

J. D. Vos, V. Pantesco, Y. Pommier, 2009, Nature Cell Biology.

Cytokines in Multiple Myeloma

J. D. Vos, B. Klein, 2004 .

Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors

J. D. Vos, M. Jourdan, B. Klein, 2000, Leukemia.

Bone marrow processing for hematopoietic stem cell transplantation: recommendations of the SFGM-TC

J. D. Vos, I. Yakoub-Agha, C. Chabannon, 2015 .

Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription

Yves Pommier, Charles Theillet, Philippe Pasero, 2010, Nature Cell Biology.

Dialogue ovocyte-cumulus: concept et applications cliniques

J. D. Vos, S. Assou, S. Hamamah, 2011 .

HIV Status does not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era

J. D. Vos, J. Gribben, S. Montoto, 2011 .

A new method for class prediction based on signed-rank algorithms applied to Affymetrix® microarray experiments

Hartmut Goldschmidt, Thierry Rème, Dirk Hose, 2008, BMC Bioinformatics.

Gene expression profiling of chronic lymphocytic leukemia can discriminate cases with stable disease and mutated Ig genes from those with progressive disease and unmutated Ig genes

J. D. Vos, F. Ajchenbaum‐Cymbalista, F. Davi, 2005, Leukemia.

Topoisomerase 1 suppresses replication stress and genomic instability by preventing interference between replication and transcription.

J. D. Vos, V. Pantesco, Y. Pommier, 2009 .

Posters * Stem Cells

S. Kim, J. D. Vos, A. Hampl, 2010 .

Amazonia!: An Online Resource to Google and Visualize Public Human whole Genome Expression Data

Thierry Rème, Tanguy Le Carrour, John De Vos, 2010 .

Omics: Tools for Personalized Reproductive Medicine

J. D. Vos, S. Assou, S. Hamamah, 2017 .

Gene Expression Profiling and Real-Time PCR Analyses Make It Possible To Identify Novel Potential Cancer-Testis Antigens in Multiple Myeloma.

J. D. Vos, G. Requirand, T. Rème, 2007 .

Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays.

J. D. Vos, K. Tarte, G. Requirand, 2001, Blood.

PostersEndometriosis, Endometrium and Implantation

J. D. Vos, R. Caprioli, P. Sparén, 2010 .

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

S. Shurtleff, J. D. Vos, L. Rassenti, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients.

J. D. Vos, T. Rème, J. de Vos, 2009, Human reproduction.

Gene Expression Profiling of Highly Purified Malignant and Non-Malignant Cells: Characterization of the Tumor-Microenvironment Cellular Synapse in De Novo Follicular Lymphoma (FL).

J. D. Vos, K. Tarte, J. Picquenot, 2007 .

Transcriptome analysis reveals dialogues between human trophectoderm and endometrial cells during the implantation period.

J. D. Vos, J. de Vos, S. Assou, 2011, Human reproduction.

Identification of new biomarkers of human endometrial receptivity in the natural cycle.

J. D. Vos, T. Rème, D. Dewailly, 2008, Human reproduction.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.

Determined by Microarray Analysis Expression Patterns and Prognosis Value Cancer/Testis Genes in Multiple Myeloma:

J. D. Vos, P. Raynaud, V. Pantesco, 2007 .

A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study.

J. D. Vos, V. Pantesco, J. de Vos, 2008, Molecular human reproduction.